March 6, 2025 About this event
This event is put on by the Canadian Drug Agency
The Drug Reimbursement Review process at Canada’s Drug Agency plays a critical role in the pathway that helps patients access new drugs. In January 2025, we published a consultation document outlining proposed improvements that aim to accelerate patient access to new medications and streamline our processes.
Join Peter Dyrda (Director, Pharmaceutical Reviews) and Michelle Gibbens (Director, Engagement) for a session that will summarize elements of the feedback we received during our consultation period and highlight the key changes to Procedures for Reimbursement Reviews.
This virtual event is open to all interested parties (registration required).